Abstract
| Lingua originale | English |
|---|---|
| pagine (da-a) | 247-256 |
| Numero di pagine | 10 |
| Rivista | European Journal of Medicinal Chemistry |
| Volume | 122 |
| Stato di pubblicazione | Published - 2016 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Pharmacology
- Drug Discovery
- Organic Chemistry
Cita questo
Synthesis and antiproliferative activity of a natural like glycoconjugate polycyclic compound. / Plescia, Fabiana; Raimondi, Maria Valeria; Daidone, Giuseppe; Raffa, Demetrio; Lauricella, Marianna; Maggio, Benedetta; D'Anneo, Antonella; Prosa, Nicolò; Scherrmann, Marie-Christine.
In: European Journal of Medicinal Chemistry, Vol. 122, 2016, pag. 247-256.Risultato della ricerca: Article
}
TY - JOUR
T1 - Synthesis and antiproliferative activity of a natural like glycoconjugate polycyclic compound
AU - Plescia, Fabiana
AU - Raimondi, Maria Valeria
AU - Daidone, Giuseppe
AU - Raffa, Demetrio
AU - Lauricella, Marianna
AU - Maggio, Benedetta
AU - D'Anneo, Antonella
AU - Prosa, Nicolò
AU - Scherrmann, Marie-Christine
PY - 2016
Y1 - 2016
N2 - A natural like O-glycoconjugate polycyclic compound 4 was obtained by a multistep procedure starting from N-(3-methyl-1-(4-nitrophenyl)-1H-pyrazol-5-yl)acetamide. The glycosyl derivative 4 showed antiproliferative activity against all the tumoral cell lines of the NCI panel in the range 0.47–5.43 μM. Cytofluorimetric analysis performed on MDA-MB231, a very aggressive breast cancer cell line, which does not express estrogen, progesterone and HER-2/neu receptors, showed that 4 is able to induce prolonged cell cycle arrest at G2/M phase and morphological signs of differentiation. These events are correlated with down-regulation of both cyclin B1 and cdc2, the cyclins involved in G2/M transition, as well as up-regulation of cyclin-dependent kinase (CDK) inhibitor p21 Cip1/Waf1.
AB - A natural like O-glycoconjugate polycyclic compound 4 was obtained by a multistep procedure starting from N-(3-methyl-1-(4-nitrophenyl)-1H-pyrazol-5-yl)acetamide. The glycosyl derivative 4 showed antiproliferative activity against all the tumoral cell lines of the NCI panel in the range 0.47–5.43 μM. Cytofluorimetric analysis performed on MDA-MB231, a very aggressive breast cancer cell line, which does not express estrogen, progesterone and HER-2/neu receptors, showed that 4 is able to induce prolonged cell cycle arrest at G2/M phase and morphological signs of differentiation. These events are correlated with down-regulation of both cyclin B1 and cdc2, the cyclins involved in G2/M transition, as well as up-regulation of cyclin-dependent kinase (CDK) inhibitor p21 Cip1/Waf1.
UR - http://hdl.handle.net/10447/180516
UR - http://www.journals.elsevier.com/european-journal-of-medicinal-chemistry/
M3 - Article
VL - 122
SP - 247
EP - 256
JO - European Journal of Medicinal Chemistry
JF - European Journal of Medicinal Chemistry
SN - 0223-5234
ER -